Innate Pharma revenue

Innate Pharma revenue increased from €44 million in 2017 to €94 million in 2018, a 113.4% increase.

Annual Revenue ()

Innate Pharma revenue was €93.95 m in FY, 2018 which is a 113.4% year over year increase from the previous period.

FY, 2017FY, 2018
Revenue€44.03 m€93.95 m

Revenue Breakdown

Business Segment

Innate Pharma revenue breakdown by business segment: 85.0% from Revenue from collaboration and licensing agreements and 15.0% from Government financing for research expenditures

FY, 2017FY, 2018
Revenue from collaboration and licensing agreements32.63 m79.89 m
Government financing for research expenditures11.40 m14.06 m